冷冻组织样本市场概况、增长、趋势、分析、研究报告(2021-2028 年)

  • Report Code : TIPRE00016644
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 167
Buy Now

Frozen Tissues Samples Market Global Analysis & Forecast 2028

Buy Now

 

冷冻组织样本市场预计将从 2021 年的 44,399.07 万美元增至 2028 年的 105,045.91 万美元。预计 2021-2028 年期间该市场的复合年增长率为 13.1%。CAGR of 13.1% during 2021–2028.

 

冷冻组织样本是新一代测序、蛋白质翻译后修饰的蛋白质印迹法、质谱法和定量实时聚合酶链式反应等分析的首选。冷冻组织样本是 DNA 和 RNA 测序的黄金标准,尤其是当链必须长于 50 对时。冷冻组织样本在免疫组织化学中也很有用,因为蛋白质仍保留其天然状态。   

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

冷冻组织样本市场:

冷冻组织样本市场
  • Frozen Tissues Samples Market
    复合年增长率(2021 - 2028 年)
    13.1%
  • 2021 年市场规模
    4,440 万美元
  • 2028 年市场规模
    1.0505 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • 奥杜邦生物科学公司
  • REPROCELL 公司
  • 海湾生物科学有限责任公司
  • 美国生物实验室有限公司
  • AMS 生物技术(欧洲)有限公司
  • 遗传学家公司
  • ZenBio 公司
  • OriGene 技术公司
  • 生物链研究所

区域概况

Frozen Tissues Samples Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Frozen Tissues Samples Market产品类别
  • 冷冻正常组织样本
  • 冷冻肿瘤组织样本
  • 冷冻病变组织样本
Frozen Tissues Samples Market应用
  • 疾病诊断与治疗
  • 癌症及其他疾病研究
  • 形态分析
Frozen Tissues Samples Market最终用户
  • 学术及研究机构
  • 医院和诊所
  • 诊断中心
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

   

全球冷冻组织样本市场的增长归因于冷冻组织样本在各个研究和治疗领域的应用日益增多,以及由于癌症发病率上升而导致的冷冻组织样本使用量增加。然而,保存和维护冷冻组织样本的风险在一定程度上阻碍了全球冷冻组织样本市场的增长。

随着癌症发病率上升,冷冻组织样本的应用也日益广泛

根据英国癌症研究中心 2020 年公布的数据,英国每年约有 16 万人死于癌症。此外,根据 Globocan 的报告,2020 年女性乳腺癌超过肺癌成为确诊人数最多的癌症,估计新增病例 230 万(11.7%),其次是肺癌(11.4%)、结直肠癌(10.0%)、前列腺癌(7.3%)和胃癌(5.6%)。肺癌仍然是癌症死亡的主要原因,估计死亡人数为 180 万(18%),其次是结直肠癌(9.4%)、肝癌(8.3%)、胃癌(7.7%)和女性乳腺癌(6.9%)。已转型国家的总体发病率是转型中国家的 2 到 3 倍。然而,转型中国家的女性乳腺癌和宫颈癌死亡率明显高于已转型国家。如此高的癌症患病率推动了对冷冻组织样本的研究需求。使用冷冻肿瘤组织样本的研究越来越多,为这种慢性病建立了多种诊断和治疗范围。因此,全球癌症发病率的上升推动了冷冻组织样本市场的增长。此外,在加拿大,癌症是人口死亡的主要原因,在美国,癌症被认为是仅次于心脏病的第二大死亡原因。根据美国癌症协会的数据,预计 2022 年美国将诊断出约 190 万例新癌症病例,死亡人数为 609,360 人。前列腺癌是北美男性中最常见的癌症;然而,乳腺癌在女性中仍然居首位。此外,肺癌仍然是人口死亡的最常见原因。据估计,每年每 100,000 名男性和女性中新发癌症病例数为 439.2 例。因此,人口中癌症患病率的上升正在导致全球冷冻组织样本市场的增长。

 

基于产品的洞察

根据产品,全球冷冻组织样本市场分为冷冻正常组织样本、冷冻肿瘤组织样本和冷冻病变组织样本。冷冻组织肿瘤样本部分在 2021 年占据了最大的市场份额。此外,预计同一部分将在 2021 年至 2028 年的预测期内在冷冻组织样本市场中实现最高的复合年增长率。增长主要归因于全球肿瘤病例的增加。  

 

基于应用的洞察

根据应用,全球冷冻组织样本市场细分为疾病诊断和治疗、癌症和其他疾病研究以及形态分析。2021 年,癌症和其他疾病研究领域占全球冷冻组织样本市场的最大份额。然而,疾病诊断和治疗领域预计将在 2021 年至 2028 年期间以 13.8% 的复合年增长率增长。

 

基于最终用户的洞察

根据最终用户,全球冷冻组织样本市场分为学术和研究机构、医院和诊所、诊断中心等。2021 年,学术和研究机构部门占据全球冷冻组织样本市场的最大份额。然而,预计从 2021 年到 2028 年,医院和诊所部门的复合年增长率最快,为 13.9%。

产品发布和批准是公司扩大其全球足迹和产品组合的常用策略。此外,冷冻组织样本市场参与者专注于合作战略来扩大客户群,这反过来又使他们能够在全球范围内保持自己的品牌名称。随着市场参与者开发新的创新产品,全球冷冻组织样本市场预计将蓬勃发展。

 

冷冻组织样本市场报告范围

报告属性细节
2021 年市场规模4,440 万美元
2028 年市场规模1.0505亿美元
全球复合年增长率(2021 - 2028)13.1%
历史数据2019-2020
预测期2022-2028
涵盖的领域按产品类型
  • 冷冻正常组织样本
  • 冷冻肿瘤组织样本
  • 冷冻病变组织样本
按应用
  • 疾病诊断与治疗
  • 癌症及其他疾病研究
  • 形态分析
按最终用户
  • 学术及研究机构
  • 医院和诊所
  • 诊断中心
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • 奥杜邦生物科学公司
  • REPROCELL 公司
  • 海湾生物科学有限责任公司
  • 美国生物实验室有限公司
  • AMS 生物技术(欧洲)有限公司
  • 遗传学家公司
  • ZenBio 公司
  • OriGene 技术公司
  • 生物链研究所
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

公司简介

  • 奥杜邦生物科学公司
  • REPROCELL 公司
  • 海湾生物科学有限责任公司
  • 美国生物实验室公司
  • AMS 生物技术(欧洲)有限公司
  • 遗传学家公司
  • ZenBio 公司
  • OriGene 技术公司
  • 生物链研究所
  • ProteoGenex 公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the Frozen Tissues Samples market?

The Frozen Tissues Samples market majorly consists of the players such as Audubon Bioscience Co; REPROCELL Inc.; Bay Biosciences LLC; US Biolab Corporation, Inc; AMS Biotechnology (Europe) Ltd.; Geneticist, Inc.; ZenBio, Inc.; OriGene Technologies, Inc.; BioChain Institute Inc.; and ProteoGenex, Inc., among others.

What is the regional market scenario of the Frozen Tissues Samples market?

The global Frozen Tissues Samples market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. Increasing incidence of cancer, growing need for diagnosing cancer, increasing competition between the market player, high R&D spending, and government grants for research institutes to develop new diagnosing methods are some of the prominent factors propelling the market growth in North America. Moreover, owing to the growing investments from international players in China and India. Aging population coupled with increasing demand for advanced medical technologies are expected to accelerate growth of the frozen tissues samples Market in Asia Pacific region.

Which end user will hold the largest share in the Frozen Tissues Samples market?

In 2021, the academic and research institutes segment was likely to hold the largest share of the market. However, the hospitals and clinics segment is expected to witness growth in its demand at the fastest CAGR of 13.8% during 2021 to 2028.

Which product will lead the Frozen Tissues Samples market?

The frozen tissue tumor samples segment was likely to hold the largest share of the market in 2021. Moreover, the same segment is anticipated to register the highest CAGR in the market during the forecast period of 2021 to 2028. The growth is mainly attributed due to increasing tumor cases globally.

What are the driving factors for the Frozen Tissues Samples market across the globe?

The factors that are driving the growth of the market are rising application of frozen tissue samples in various research and therapeutic areas and risk associated with preservation and maintenance of frozen tissues samples. Moreover, the proliferation of biotechnology industry in developing regions provide growth opportunities to the frozen tissues samples market and developments in frozen tissue samples is expected to be a future trend that will drive the market’s growth in the coming years.

What are Frozen Tissues Samples?

Frozen tissue samples are biospecimens preferred in analyses such as next-generation sequencing, western blotting for post-translational protein modifications, mass spectrometry, and quantitative real-time polymerase chain reaction. Frozen tissue samples are the gold standard for DNA and RNA sequencing, especially when the strands must be longer than 50 pairs. In immunohistochemistry, frozen tissue samples are also useful as the proteins are still preserved in their native state.

The List of Companies - Frozen Tissues Samples Market

  1. Audubon Bioscience Co
  2. REPROCELL Inc.
  3. Bay Biosciences LLC
  4. US Biolab Corporation, Inc.
  5. AMS Biotechnology (Europe) Ltd.
  6. Geneticist, Inc.
  7. ZenBio, Inc.
  8. OriGene Technologies, Inc.
  9. BioChain Institute Inc.
  10. ProteoGenex, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Biotechnology : READ MORE..